SOTERA HEALTH COMPANY Proceeds from Long-Term Debt Issued
SOTERA HEALTH COMPANY (SHC) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-02-24
- SOTERA HEALTH COMPANY proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $0.00.
- SOTERA HEALTH COMPANY proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was $0.00.
- SOTERA HEALTH COMPANY proceeds from issuance of long-term debt for the quarter ending 2024-12-31 was $0.00.
- SOTERA HEALTH COMPANY proceeds from issuance of long-term debt for the quarter ending 2024-09-30 was $0.00.
- SOTERA HEALTH COMPANY proceeds from issuance of long-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SOTERA HEALTH COMPANY proceeds from issuance of long-term debt for fiscal 2024 was $2.26B, a 351.87% increase from fiscal 2023.
- SOTERA HEALTH COMPANY proceeds from issuance of long-term debt for fiscal 2023 was $500.00M, a 150.00% increase from fiscal 2022.
- SOTERA HEALTH COMPANY proceeds from issuance of long-term debt for fiscal 2022 was $200.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $2.26B derived: sum of 3 quarters · filed 2026-02-24 | $2.26B 10-K · filed 2026-02-24 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.26B derived: sum of 2 quarters · filed 2025-11-04 | $2.26B 10-Q · filed 2025-11-04 | $2.26B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $2.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $2.26B 10-Q · filed 2025-08-08 | $2.26B derived: sum of 3 quarters · filed 2026-02-24 | $2.26B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $500.00M 10-K · filed 2026-02-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $500.00M 10-Q · filed 2024-11-05 | $700.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $500.00M 10-Q · filed 2024-08-05 | $700.00M derived: sum of 3 quarters · filed 2025-02-27 | $700.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $500.00M 10-Q · filed 2024-05-02 | $700.00M derived: sum of 2 quarters · filed 2025-02-27 | $700.00M derived: sum of 3 quarters · filed 2025-02-27 | $700.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $200.00M derived: sum of 2 quarters · filed 2025-02-27 | $200.00M derived: sum of 3 quarters · filed 2025-02-27 | $200.00M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $150.00M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $3.14B 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |